KG
Kelsey Goodwin Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
18
Avg Return
Past Year
Past Year
43%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.4%
Neutral
5.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $24 |
328%
upside
| 1 | +9.6% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Overweight
Initiated
| $22 |
160%
upside
| 1 | +3.8% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Overweight
Initiated
| $5 |
14%
downside
| 1 | +60% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Overweight
Assumed
| $9 |
224%
upside
| 1 | -31% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $26 |
181%
upside
| 1 | +27% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $128 |
25%
upside
| 2 | +17% |
0
%
| 27 Oct ‘25 2 months ago |
|
|
|
Neutral
Initiated
| $21 |
12%
upside
| 1 | – |
–
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $42 |
202%
upside
| 1 | -46% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $75 |
30%
downside
| 1 | +195% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $36 |
53%
upside
| 3 | +31% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $55 |
31%
upside
| 1 | +60% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $11 |
0%
downside
| 1 | +53% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $36 |
117%
upside
| 1 | +44% |
0
%
| 19 Aug ‘25 4 months ago |
|
|
|
Buy
Reiterated
| – | – | 2 | +111% |
0
%
| 28 Mar ‘25 9 months ago |
|